* Avanos Medical Inc AVNS.N reported quarterly adjusted
earnings
of 38 cents per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was
for earnings of 35 cents per share.
* Revenue rose 9.8% to $202.10 million from a year ago;
analysts
expected $205.47 million.
* Avanos Medical Inc's reported EPS for the quarter was 33
cents.
* The mean earnings estimate of analysts had fallen by
about 22.4%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* Avanos Medical Inc shares had risen by 3.0% this
quarter and
lost 35.3% so far this year.
* The company reported a quarterly loss of $15.4 million.
* Wall Street's median 12-month price target for Avanos
Medical
Inc is $31.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
2 at 01:31 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 0.35 0.38 Beat
Jun. 30 2022 0.38 0.41 Beat
Mar. 31 2022 0.26 0.26 Met
Dec. 31 2021 0.40 0.46 Beat